Key Words JAK/STAT pathway, cell mobility, HIV-1 coreceptors s Abstract A broad array of biological responses, including cell polarization, movement, immune and inflammatory responses, and prevention of HIV-1 infection, are triggered by the chemokines, a family of structurally related chemoattractant proteins that bind to specific seven-transmembrane receptors linked to G proteins. Here we discuss one of the early signaling pathways activated by chemokines, the JAK/STAT pathway. Through this pathway, and possibly in conjunction with other signaling pathways, the chemokines promote changes in cellular morphology, collectively known as polarization, required for chemotactic responses. The polarized cell expresses the chemokine receptors at the leading cell edge, to which they are conveyed by rafts, a cholesterol-enriched membrane fraction fundamental to the lateral organization of the plasma membrane. Finally, the mechanisms through which the chemokines promote their effect are discussed in the context of the prevention of HIV-1 infection.
Since the description of the first chemokine (PF4) in 1961, many different chemoattractant cytokines have been characterized. Their role in migration and their specificity for various leukocyte subsets have been characterized in detail. Significant advances have been made in recent years in understanding the role of chemokines (4) in inflammatory diseases (5) , hematopoiesis, angiogenesis, metastasis, tumor rejection (6) , Th1/Th2 responses (7, 8) , and HIV-1 infection. This last case, that is, the neutralizing effect of chemokines on HIV-1 infection and the characterization of chemokine receptors as HIV-1 coreceptors, has triggered new studies of chemokines and their mechanism of action (9) (10) (11) . Future directions in chemokine research include the characterization of chemokine antagonists, which will open up therapeutic opportunities for autoimmune diseases, transplantation, and immune deficiencies (12) .
CHEMOKINE RECEPTORS
Chemokines exert their effects by interaction with seven-transmembrane, G protein-coupled receptors (GPCR) present in the membrane of the target cell. All of these receptors are comprised of approximately 350 amino acids and a molecular weight around 40 kDa. The extracellular domain consists of the N-terminus and three extracellular loops that act in concert to bind the chemokine ligand. The intracellular region is composed of three loops and the C-terminus, which also collaborate to transduce the chemokine signal. Based on their amino acid sequences, chemokine receptors belong to the class A rhodopsin-like family. Although similar to other seven-transmembrane receptors, the chemokine receptors share certain structural features, such as the highly conserved DRYLAIV amino acid sequence in the second intracellular loop (13) .
As is the case for the chemokines, the receptors can also be grouped into four major families, CR, CCR, CXCR, and CX3CR, which interact with the C, CC, CXC, and CX3C chemokines, respectively. Their structural similarity has aided in the identification of new chemokine receptors, in many cases even before the ligand is described. The HIV-1 coreceptor CXCR4 was cloned several years ago, for example, and designated LESTR at the time; it was classified as a putative chemokine receptor based on its similarity to IL-8 receptors and to CCR1 and CCR2 (14) .
Several caveats must be considered when chemokine signaling is being evaluated. First of all, chemokine receptor expression on the cell surface is highly variable; that is, although mRNA may be found in a cell, it does not always correspond to functional receptor expression but corresponds rather to an internal pool in many cases. Second, the use of GFP fusion proteins and tagged receptors, which substitute for the lack of appropriate receptors, have limited the study of chemokine signaling to transfected cells; their use may also alter both expression and signaling in these modified receptors. The lack of reliable chemokine-specific reagents has impeded characterization of the biochemical pathways associated with chemokine responses, although a number of recently produced chemokine receptor-specific monoclonal antibodies are now helping to elucidate some of the chemokine-triggered intracellular signals. Much of the information we have today about chemokine signaling has been deduced mainly from available information on GPCR signaling. Known pathways for other GPCR that have been studied include G protein coupling, JAK/STAT, as well as both tyrosine and Ser/Thr kinases (15) (16) (17) .
SIGNALING THROUGH CHEMOKINE RECEPTORS Chemokine Receptor Dimerization and Activation of the Tyrosine Kinase Pathway
Despite substantial recent advances in our understanding of chemotaxis, the precise mechanism through which cells respond to a chemotactic gradient remains unclear. Leukocyte motion involves several phenomena, including changes in cell shape, changes in integrin affinity, and integrin recycling at the cell's leading edge (18) . These events appear to be mediated by phosphorylation signals triggered through chemokine receptors, although the signal transduction machinery implicated has only begun to be elucidated (15) . Figure 1 shows a scheme illustrating the main signaling pathways described to date; these pathways are activated following ligand binding to chemokine receptors and lead to a number of important cellular consequences including gene expression, cell polarization, and chemotaxis. All GPCR share a core domain consisting of the seven transmembrane helices; conformational changes in this domain are believed to be responsible for receptor activation. Similar conformational changes can be elicited by a wide variety of ligands including light, Ca 2+ , pheromones, and small molecules (amino acids, amines, nucleotides, prostaglandins, peptides) or proteins (glycoproteins, interleukins, chemokines), suggesting the existence of a large variety of molecular mechanisms that induce such activation (19) . GPCR may exist in equilibrium between two conformational states, active and inactive; the presence of an agonist would drive this balance toward the active state, whereas an antagonist would favor the inactive form. Like other GPCR, some if not all chemokine receptors initiate their ligand-induced signaling cascades by receptor dimerization (20) (21) (22) .
Our laboratory has concentrated its efforts on understanding the mechanisms behind the activation of the tyrosine kinase pathway by chemokines, as well as its biological significance. We thus focus here on the study of ligand-mediated chemokine receptor dimerization, a phenomenon that has been observed in many receptor families, including the seven-transmembrane GPCR.
Chemokine receptor dimerization was first demonstrated for CCR2, the MCP-1 receptor. The similarity among chemokine receptors, including conservation of the DRY motif, nonetheless suggests that dimerization and JAK/STAT pathway activation are not exclusive to CCR2 but are found for other chemokine receptors, including members of the CCR and CXCR families. This is the case for CCR5 and CXCR4, both of which induce activation of different JAK/STAT family members. In the CCR5-transfected HEK-293 cell response to RANTES, CCR5 is rapidly tyrosine phosphorylated, and JAK1, but not JAK2 or JAK3, associates with the receptor (21) . JAK1 association in response to RANTES promotes STAT5b transcriptional factor association to the receptor, as well as its activation. Activation of STAT transcriptional factors was also seen in T cells after RANTES and MIP-1α stimulation (23) ; in this case, STAT1 and STAT3 are implicated, both of which induce expression of the STAT-inducible proto-oncogene c-fos. In addition, SDF-1α promotes rapid activation and association of JAK1 and JAK2 to the CXCR4. This activation promotes STAT1, 2, 3, and 5b association to the CXCR4, followed by its activation (22) .
In the CCR2, tyrosine Y139 in the DRY motif has been identified as the primary target for JAK2-mediated CCR2b receptor phosphorylation (16) . A CCR2b mutant receptor in which this residue has been replaced by phenylalanine (CCR2bY139F) retains its capacity to form homodimers in response to MCP-1 stimulation, but it shows impairment of Gα i association to CCR2b and thus of G i -mediated effects such as calcium mobilization and chemotaxis. This is a direct consequence of the lack of CCR2b phosphorylation and JAK2 activation. When CCR2bY139F is coexpressed with wild-type CCR2b in HEK-293 cells, these cells are unable to signal in response to MCP-1. This is because of the inability of the CCR2bY139F mutant to be phosphorylated on Tyr, rendering it unable to recruit and trigger JAK2 phosphorylation and association to the receptor, impeding G i activation. This shows that CCR2bY139F acts as a CCR2b dominant negative mutant, blocking chemokine responses by its ability to form nonproductive complexes with partners containing the functional domain, demonstrating the significance of dimerization in chemokine responses. These data also show that, in the absence of JAK activation, chemokine signaling through chemokine receptors does not occur, as confirmed by the observation that G protein-mediated signaling events are blocked by JAK kinase inhibitors (16) .
Although reports of chemokine receptor dimerization and chemokine-mediated JAK/STAT activation are relatively recent, several lines of evidence suggest that GPCR dimers may have an important role in signaling (24) . Examples include the chimeric α2-adrenergic-m3-muscarinic receptors (25) , as well as the angiotensin (AT1) (26), V2-vasopressin (27) , β2-adrenergic (28), δ-opioid (29), mGluR5 (30) , and calcium-sensing receptors (31) . It is interesting to note that, as for the chemokine receptors, this activation is apparently independent of G protein-related events (32) .
In another member of the seven-transmembrane receptor family, the response to GABA requires heterodimerization of the GBR1 and GBR2 receptors (33) (34) (35) . Physical interaction between GBR1 and GRB2 appears to be essential for the activation of potassium channels. More recently, another group of GPCR, the opioid receptors, were shown to undergo heterodimerization (36) . In this case, there is clear biochemical and pharmacological evidence for the heterodimerization of two functional opioid receptors, κ and δ. Heterodimerization of these two receptors causes synergistic agonist binding and potentiates the biological signal, although there are no biochemical data to explain this heterodimer-triggered synergistic response. A similar observation has been recently made for the dopamine and the somatostatin receptors (37) .
Both the dimerization of chemokine receptors and the extensive sequence identity among some of them strongly suggest that chemokine receptors may heterodimerize. In fact, chemokine receptor heterodimerization could be the mechanism by which individuals with the CCR2V64I allele show delayed AIDS progression (11) . As for other GPCR, chemokine receptor heterodimerization would have important functional consequences, including increases in the sensitivity of some responses (37) or initiation of signaling events not triggered by individual chemokines, such as specific recruitment of non-G i proteins (38) .
Activation of Chemokine Receptor-Associated G Proteins
The classical view of chemoattractant receptor signaling requires activation of the G protein pathway after chemokine binding. The majority of these responses are inhibited by PTX treatment, indicating that members of the G i protein family are the primary transduction partners associated with the receptors (13, 39) ( Figure 1 ). Physical association of Gα i to several chemokine receptors has been described; these include CXCR1 (40), CCR2 (16), CCR5 (21) , and CXCR4 (22) , following activation by IL-8, MCP-1, RANTES, and SDF-1α, respectively. Signaling studies of the CC chemokine receptors in transfected HEK-293 cells revealed potent, agonist-dependent inhibition of adenylyl cyclase and mobilization of intracellular calcium, consistent with receptor coupling to Gα i (41) . In some studies, PTX did not completely block the calcium response, suggesting that chemokine receptors may couple to G proteins other than G i , such as G q or G 16 , depending on the chemokine receptor studied; this indicates that receptor/G protein pairings may be cell type-specific (42, 43) . Although chemokine responses in many leukocytes require G i activation, leukocytes express G i -coupled receptors that are not known to induce chemotaxis (44) . It thus appears that G i activation, although necessary, is not sufficient for chemotaxis. The role of G i may thus be due to the indirect effect of Gα i sequestration of Gβγ subunits, which has been described to prevent the chemotactic response (45) (46) (47) . A direct effect of Gα i on some other signaling pathway cannot be ruled out.
Following activation by the chemokine-triggered receptor, the heterotrimeric Gαβγ protein dissociates into the Gβγ subunit complex and the GTP-bound Gα i subunit. Gα i binds the receptor, probably by interaction with one or more intracellular loop regions (42) ; this is a consequence of conformational changes promoted in the chemokine receptor by ligand binding, Janus kinase association, and tyrosine phosphorylation of the receptor. Both events, receptor association and subunit dissociation, initiate independent intracellular signaling responses by acting on distinct effector molecules.
The Gβγ subunits trigger PLC activation (48) , DAG activates various protein kinase C (PKC) isoforms; PKC then activates a cascade of signal transduction events both intracytoplasmically and within the nucleus. Gβγ also acts as a docking protein, providing an interface for the GPCR, which would facilitate GPCR interaction in diverse signaling pathways. This is the case for the coupling of the G protein-coupled receptor kinases (GRK) (49) , which are involved in chemokine receptor desensitization (see below).
CC chemokines also activate phospholipase A 2 (PLA 2 ) and the release of arachidonic acid in human monocytes (50, 51) . Arachidonic acid seems to be involved in or at least closely associated with the chemotactic response; in fact, PLA 2 inhibitors decrease chemokine-induced monocyte migration in a concentrationdependent manner (52) . Phospholipase D (PLD) activation by chemokines has been reported (53) , although its significance is speculative and details of its regulation in leukocytes remain to be elucidated.
Shutdown of G protein-activated signals is dependent on Gα subunit GTPase activity. The slow hydrolysis of GTP to guanosine diphosphate (GDP), which remains protein-bound, promotes dissociation of the Gα subunit from effectors and reassociation with the Gβγ subunit. The slow intrinsic rate of GTP hydrolysis by Gα proteins is regulated by interactions with GTPase-activating proteins (GAP). There is a large, newly discovered family of GAP for Gα proteins, known as regulators of G protein signaling, or RGS proteins, which act as negative regulators of G protein signaling (54, 55) by interacting directly with Gα so that it cannot interact with effectors or with Gβγ (56). It is not yet known how RGS are regulated in vivo, nor has their role in chemokine signaling been demonstrated, although it has been shown that the CXCR2 receptor can specifically interact with the PDZ domain of RGS12 (55) and that RGS1 desensitizes a variety of chemotactic receptors, such as those of N-fMLP and leukotrienes B4 and C5 (57) .
The classical view of chemokine signaling involving G proteins is more complex than expected. Although some chemokine-mediated responses are clearly linked to Gα i proteins, other effects appear to be mediated by other G proteins or by Gβγ subunit release. Further studies may elucidate the role of the distinct G proteins in chemokine signaling and the functional consequences.
Chemokines Trigger Phosphatidylinositol 3-Kinase (PI3K) Activation
PI3K activity is rapidly stimulated by chemoattractants (58, 59 ) (see also Figure 1 , color insert) SDF-1α activates PI3K and induces p85 association to CXCR4 (60) . This results in the generation of 3-phosphorylated lipids that act as second messengers for downstream effectors such as PKC, AKT, and Ras pathways (61) . This activation has been implicated in integrin adhesiveness, cell migration, and polarization (62) . In PI3Kγ KO mice, it has recently been shown that migration in response to chemoattractants is impaired but not eliminated, suggesting that this specific G protein-activated PI3K subtype is important in, but not essential to, chemotaxis (63) . In fact, the major effect of PI3K inhibition in neutrophils appears to be blockade of NADPH oxidase activity (63) (64) (65) , although it is also involved in cytoskeletal change phenomena necessary for polarization (58, 60) . Some studies suggest that the p85 subunit SH2 domain may be required for its association with the tyrosine-phosphorylated p125 FAK (66) . Furthermore, the association between p125 FAK and the activated CCR5 receptor has been shown using CCR5-transfected cells (21) . Signaling through the CCR5 receptor leads to phosphorylation and activation of a recently discovered FAK family protein kinase, Pyk2 (also known as RAFTK or CAK-β) (67, 68) . This activation results in downstream modulation of the JNK/SAPK kinase system. Activation of the FAK kinases by chemokines acting through CCR5 results in phosphorylation of the cytoskeletal protein paxillin and its association to this receptor.
Recent studies in whole human PBL reveal that inhibition of PI3K activity by chemical compounds or by overexpression of its dominant negative form prevent the polarization of adhesion molecules and of several cytoskeletal elements such as the protein moesin of the ezrin/radexin/moesin (ERM) complex. These data indicate that PI3K activation induces polarization of adhesion molecules (60) . Other PI3K effectors include the low-molecular-weight GTPases, such as Rho, Rac, and Cdc42, which participate in regulation of the actin cytoskeleton and cell adhesion through specific targets (69, 70) .
In conclusion, PI3K activity is an important mediator of chemotactic responses. Although all PI3K isoforms generate intracellular messengers such as PIP3, a general signal for migration responses, further studies are required to obtain a more complete view of their individual contributions in the variety of events that lead to cell migration.
Ser/Thr Phosphorylation of Chemokine Receptors
Lymphocyte trafficking is a complex process controlled by a vast array of molecules. These cells must be able to detect minimal changes in chemoattractant gradients; for this, cells probably employ an on-off mechanism in which chemokine receptor desensitization may be an important step. Little is known of the regulatory mechanisms in the cellular response to chemokines, or of the role of desensitization in lymphocyte migration. For a large number of related GPCR, rapid desensitization appears to involve agonist-promoted receptor phosphorylation by members of the GRK family (71) . GRK-mediated phosphorylation of Ser/Thr residues in the carboxyl tail and/or intracellular loops of GPCR increases affinity for arrestin-type proteins, the binding of which prevents any further coupling between the receptor and G proteins (72) . Following chemokine stimulation, receptors of both CXC and CC chemokine families are phosphorylated at multiple serine residues in the C-terminal domain by GRK enzymes (73) (74) (75) (76) (77) (78) . This phosphorylation is similar to that observed for several other GPCR and is critical in receptor function, as it mediates receptor desensitization and internalization into vesicular compartments. This phosphorylation was first described for CCR2 (73, 78) and later extended to other chemokine receptors (79-81) that, following ligand-induced activation, form a macromolecular complex with GRK and the regulatory protein β-arrestin. Variations in GRK family member use by receptors appear to reflect GRK availability in the cells employed rather than a specific GRK-chemokine receptor relationship.
During the GRK2-mediated desensitization process, both GRK2 catalytic activity and the CCR2b C-terminal domain Ser/Thr residues are critical. Coexpression of GRK2 and CCR2 blocks MCP-1-induced responses. When a CCR2 receptor mutant lacking Ser/Thr residues in the carboxyl tail was expressed, the MCP-1-induced signal was not inhibited by GRK2 coexpression (78) . This critical role for GRK kinase in CCR2 deactivation was also shown when the CCR2 receptor was coexpressed with a dominant-negative mutant of GRK2 (82); the cellular response to a second MCP-1 challenge was equivalent to the original response (73) . A similar response to ligand challenge was observed by expressing a truncated C-terminal form of the CXCR2 receptor or a receptor mutated in Ser and Thr residues (80, 81) . The active role of β-arrestin in receptor internalization is indicated by the fact that dominant negative mutants of this protein block CXCR1 internalization (83) .
Synaptic vesicle recycling and endocytosis of many receptors, including GPCR, require the GTPase activity of dynamin (84) . Coexpression of CXCR2 or CXCR1 with a dominant negative dynamin mutant inhibits receptor internalization (83, 85) , and RANTES promotes a transient association between dynamin and CCR5 in the clathrin vesicles that mediate internalization (79) . Figure 2 shows the sequence of chemokine signaling events that leads to receptor internalization.
As for other GPCR, the turning off of chemokine receptors thus requires the participation of different molecules, including GRK, arrestin, clathrin, and dynamin; this leads to receptor internalization to the endosome, where the receptor will be dephosphorylated and either recycled to the cell surface or degraded. This process may have a more direct role, as it has been suggested for other GPCR that internalization is needed to activate specific signaling cascades (86, 87) .
Activation of the MAP Kinase Cascade
MAP kinases (MAPK), also known as extracellular signal-regulated kinases (ERK), are activated by phosphorylation of Tyr/Thr residues (88, 89) and regulate several different proteins, including oncogenic transcription factors and protein kinases. MAPK activation of PLA2 (90) and cytoskeletal elements (91) suggests a specific role for this signaling cascade in chemokine-induced cellular responses. Stimulation of human neutrophils with f-MLP activates Ras (92) , which initiates the MAPK cascade by binding to the Ser/Thr kinase Raf. Ras translocates Raf from the cytoplasm to the plasma membrane (93) , where it is activated through interactions with members of the 14-3-3 protein family (94, 95) . Both Raf and MEKK, another MAP kinase, phosphorylate and activate MAPK (59, 96) .
PTX treatment blocks chemokine activation of the MAPK cascade in neutrophils, indicating that the activation of this kinase is a process mediated via G i . With COS-7-transfected cells and transient MAPK coexpression with GPCR, activated Gα i subunits failed to mimic receptor stimulation of MAPK activity, evidence of the active role of Gβγ dimers in this signaling pathway. Under different experimental conditions, MAPK activation by Gβγ subunits required neither PLC-β nor PKC activation but was blocked by dominant interfering mutants of Ras (97, 98) ; Gβγ subunits induced accumulation of the GTP-bound, active form of Ras.
Chemokine activation of MAPK has a number of functional consequences. As MAPK can phosphorylate and activate transcription factors (99) , chemokines may be involved in regulation of gene expression through this pathway ( Figure  1) . Furthermore, MAPK phosphorylates and activates cytoplasmic PLA2, leading to release of arachidonic acid and phospholipid (100). Arachidonic acid-induced leukotriene production is essential for actin polymerization (101) . These data also indicate a chemokine-induced pathway involving MAPK and cPLA2 that may regulate cytoskeletal changes necessary for cell migration. In any case, this function may not be critical, as the p38-MAPK inhibitor SK&F 86002 has no significant effect on chemokine-mediated chemotaxis or chemokinesis (102).
CHEMOKINE-TRIGGERED BIOLOGICAL RESPONSES Cell Polarization: Chemokine Receptor Expression at the Leading Cell Edge
Cell migration has a crucial role in a wide variety of biological phenomena. It is of particular importance for leukocyte function and in the inflammatory response. For a cell to begin to migrate, the acquisition of a polarized morphology that allows cell locomotion appears to be required. This morphology is also involved in a number of other processes, such as cell differentiation, vectorial transport of molecules across cell layers, induction of the immune response, and recognition and binding of APC by T cells. Cytolytic T lymphocytes and natural killer (NK) cells maintain a polarized phenotype when bound to their targets, and they initiate the polarized secretion of cytolytic granules, which are required for proper cell-killing function (103, 104) .
Chemokines and other chemotactic cytokines induce T, B, and NK cell as well as phagocyte polarization (103) (104) (105) (106) . One of the earliest events in chemoattractantinduced leukocyte polarization is a change in cell distribution of filamentous F-actin, from a radial symmetrical pattern to concentration in specific cell regions. As a consequence, two differentiated areas are established in the cell, the leading edge and the uropod. The uropod, which is not observed in other migrating eukaryotic cells, is a pseudopod-like projection that represents a specialized structure with important motility and adhesion functions. The leading cell edge concentrates several receptors, including the αvβ3 integrin, receptors for classic chemoattractants such as the fMLP receptor, and chemokine receptors such as CCR2, CCR5, and CXCR4 in lymphocytes. The redistribution of chemokine receptors to the leading edge is triggered by several chemotactic factors and by cytokines such as IL-2 and IL-15. In migrating cells, a number of adhesion molecules are concentrated in the uropod, among them ICAM, L-selectin, PSGL-1, Mac-1, and CD43. The presence of these molecules in the uropod promotes the binding of other cells, enhancing leukocyte recruitment and transendothelial migration (18) .
The presence of chemokine receptors at the leading cell edge implies the establishment of endogenous polarity but also the specialization of this cell domain to detect the chemoattractant gradient. Cell polarization thus correlates with orientation toward the chemoattractant source. The signal transduction molecules coupled to the activated chemokine receptors also localize at the advancing front of the cell. Chemokine activation of G i protein signaling events at the stimulated edge of chemotactic cells has also been described in other models (107) ; this led to the proposal of a model in which receptor activation at the stimulated cell edge recruits molecules that signal the cytoskeleton directly. Some evidence indicates recruitment of the pleckstrin homology domain of the AKT protein kinase to the leading edge of neutrophils activated by chemoattractant molecules, in a process requiring one or more Rho guanosine triphosphatases (108) . The Rho family of GTPases has a major role in regulating the actin cytoskeleton, which organizes membrane protrusion and focal adhesion, and in regulating cell polarity during leukocyte migration. The mechanisms through which Rho GTPases exert their effects have not been completely elucidated, although some actin-binding proteins may be the effectors (109, 110) .
Chemokines also induce NK cell polarization and redistribution both of adhesion molecules to the uropod and of chemokine receptors to the leading cell edge. This observation assigns chemokines an important role in the NK cell cytotoxic response (104, 111) . The leading edge is involved in target cell adhesion, in granule release during cytotoxic phenomena, and in directing cell migration, whereas the uropod has functions related to leukocyte recruitment. The formation of NK-target cell conjugates induces the release of chemokines responsible for NK cell migration, an effect that is mimicked by in vitro activation of NK cells.
The morphological asymmetry characteristic of polarized lymphocytes reflects the spatial rearrangement of several molecules, including cytoskeletal proteins, membrane receptors, and signaling molecules. Lymphocyte polarization is essential not only for cell migration, but also in leukocyte effector functions such as T helper cell interactions with antigen-presenting cells, as well as during target cell recognition and killing by NK and cytotoxic T cells.
Chemokine Receptors Are Transported to the Leading Cell Edge in Rafts
The redistribution of chemokine receptors and the associated trimeric G proteins at the leading edge of the moving cell correlates with the acquisition of a migrating phenotype. The mechanisms involved in chemokine receptor transport to the leading edge has only recently come to be understood. Cell polarization may be considered the final result of complex mechanisms that establish and maintain functionally specialized domains in the plasma membrane during cell migration. Favoring this view, the signals that trigger and maintain asymmetric chemokine receptor redistribution in leukocytes appear to be independent of the polarizationinducing agent used (103, 112) . This suggests that cell asymmetry is not the consequence of chemoattractant receptor distribution but that protein redistribution is the final result of the polarization process.
Migrating cells are not the only cells that segregate proteins into specific plasma membrane regions. In polarized cell types such as neurons or epithelial cells, distinct plasma membrane domains (apical and basolateral compartments for epithelia, and axon and dendrites for neurons) differ strongly in lipid and protein composition (113, 114) . It is proposed that the asymmetric distribution of membrane proteins among apical and basolateral membranes (for epithelia) or axon and dendrites (for neurons) is achieved by specific co-sorting with glycosphingolipids in vesicular carriers (114) (115) (116) . According to this model, specific membrane proteins clustered with glycosphingolipids and cholesterol-enriched membrane rafts in the trans-Golgi network (TGN) would be delivered preferentially to the apical membrane or to the axon (117) . In nonpolarized cells such as BHK, CHO, or 3T3 fibroblasts, several membrane proteins are also delivered with glycosphingolipids in vesicular carriers from the TGN to the cell surface (118) (119) (120) . These proteinlipid complexes are conserved on the surface of living cells (121, 122) , where they are viewed as moving platforms of highly ordered membrane that transport specific proteins. Because of their lateral and rotational mobility, lipid rafts are fundamental in the lateral organization of the proteins anchored to the plasma membrane (123) .
Several lines of recent evidence suggest that segregation between raft and nonraft proteins in unstimulated cells is crucial in distributing specialized molecules to specific locations during cell polarization (124) . First, chemokine receptors associate with membrane raft microdomains, and receptor asymmetry parallels the preferential leading edge redistribution of other raft-linked molecules, including GM1, glycosylphosphatidyl inositol-anchored green fluorescent protein (GFP-GPI), and ephrinB1; conversely, proteins not located in rafts are distributed homogeneously over the cell surface. Second, modification of proteins such that they do not associate with rafts inhibits their asymmetric redistribution in polarized cells. Indeed, the non-raft-associated mutant ephrinB1 C (125) is distributed homogeneously in the plasma membrane of migrating cells, whereas raft-associated ephrinB1wt redistributes to the leading edge of polarized cells. Third, the protein redistribution is not restricted to molecules with functional significance, as redistribution of GFP-GPI and chemokine receptors to the leading edge occurs simultaneously. This result highlights that raft association is the pivotal determinant for the redistribution of proteins to the leading edge of polarized cells, and so the result supports the observation that asymmetric chemokine receptor distribution to the leading cell edge is a phenomenon that reflects the cell polarization process.
Cell asymmetry thus appears to be dependent on protein association with rafts; disruption of raft structure, and hence function, would render cells unable to achieve a polarized phenotype. Raft function can be abrogated by chemical sequestration of cholesterol from the membrane (120) . Cholesterol depletion impedes chemokineinduced cell polarization and inhibits cell chemotaxis, which can be restored by replenishing the plasma membrane with cholesterol (124) . Cholesterol depletion does not, however, inhibit chemoattractant-mediated early signaling or recruitment of the signaling-associated receptor complex. Collectively, these results indicate that raft integrity is required for the acquisition of front-rear polarity and, consequently, for cell motility. Since cholesterol depletion treatment abolishes the association of chemokine receptors with raft membrane microdomains (124), these findings suggest that chemoattractants engage all the signaling machinery necessary to induce cell polarization, using the lipid rafts as platforms.
Chemokines Prevent HIV-1 Infection
In the mid-1990s, the protective role of chemokines in HIV-1 infection was described (126) , as was the fact that chemokine receptors, in conjunction with CD4, could act as HIV-1 coreceptors (127). Today we know that T-tropic HIV-1 strains use CXCR4 as a coreceptor, whereas CCR5 is the entry cofactor for M-tropic isolates (128) . An important advance in understanding the role of chemokine receptors as HIV-1 receptors was the identification of a CCR5 polymorphism that renders homozygous individuals highly resistant to viral infection (129, 130) . This polymorphism is a 32-base-pair deletion (ccr5-32) that results in the production of a truncated receptor molecule not expressed on the cell surface; ccr5-32 homozygous individuals are thus resistant to infection by M-tropic HIV-1 viral strains (129) . In addition to CXCR4 and CCR5, other receptors show limited coreceptor activity, as is the case of CCR2, CCR3, CCR8, CCR9, CXCR3, or the orphans Bonzo and BOB (10, 131) . This discovery provided new perspectives on fundamental aspects of HIV-1 transmission and pathogenesis, and it suggests fresh approaches for the development of anti-AIDS therapies. Nonetheless, current understanding of the events triggered by chemokine or virus interaction with chemokine receptors is based on observations made using different, not always comparable methods. This, and the variable expression of chemokine receptors depending on cell line, donor, and activation method employed, renders both chemokine signaling and its implications in HIV-1 infection a complex although promising field.
HIV-1 entry into a cell is a multistep process that involves high-affinity interaction with CD4, which is thought to trigger the conformational changes (132) needed for subsequent interaction with chemokine receptors (133) . The coreceptors represent new players in the fusion process, leading to more complex models involving multiple protein-protein interactions and conformational changes. Several chemokine receptor regions have been implicated in this interaction, based on receptor chimeras, point mutation studies, comparison of chemokine receptor homologues from different species, and analysis of the blocking activity of chemokine analogues and anti-chemokine receptor antibodies. Although the results are extremely complex and sometimes contradictory, certain conclusions can be drawn. In the CCR5, there is a clear role for the N-terminal region and one of the extracellular loops in the maintenance of viral infection (134, 135) . For CXCR4, the N-terminal region does not have such a critical part in viral interaction; the extracellular loops account for most of the residues involved in binding with the viral env proteins. The transmembrane regions also influences activity, however, probably affecting the display of the extracellular regions.
Several mechanisms have been postulated by which chemokines inhibit HIV-1 infection (136-139) , as illustrated in Figure 3 . One, the so-called steric hindrance model, holds that chemokine binding to its receptor blocks interaction of the HIV-1-env/CD4 complex with the receptor. Results of experiments using modified chemokines that are antagonists in functional assays such as chemotaxis indicate that this may be a mode of blockage (138, 139) . Nonetheless, earlier studies indicate that the CCR5 domains involved in chemokine ligand specificity and in coreceptor usage for various HIV-1 strains are not identical (140) . Whereas N-terminal-specific mAb block gp120-CCR5 binding very efficiently, antibodies specific for the second extracellular loop are more potent in preventing viral infection.
Another model suggests that chemokines induce chemokine receptor desensitization and internalization, preventing viral interaction with and infection of the target cell; evidence for this mode of action has also been reported (137) . This model allowed generation of potent chemokine agonists that induce receptor internalization, preventing HIV-1 infection. This is the case of an N-terminally modified RANTES protein, aminooxypentane-RANTES (AOP-RANTES), a potent inhibitor of infection by M-tropic HIV-1 strains in monocytes and lymphocytes (139) . AOP-RANTES treatment results in a rapid decrease in surface CCR5 expression in these cells (79, 139) .
The third possibility is that the receptor undergoes a conformational change after chemokine binding, giving rise to a structure no longer recognized by the virus. A conformational change, dimerization, indeed follows chemokine or antibody binding; this may in turn impede the interaction between HIV-1 gp120 and the chemokine receptor (141) . Indeed, monoclonal antibodies have been described that block HIV-1 infection with no detectable CCR5 activation and that trigger receptor dimerization (141) .
Receptor dimerization has also been used to explain certain cases of resistance to HIV-1 infection. Thus, several studies describe CCR2V64I, a CCR2-related polymorphism (142) characterized by a conservative valine-to-isoleucine change at position 64 in the first CCR2 transmembrane domain, a region with complete amino acid sequence identity to CCR5. The allele is found in all ethnic groups tested with frequencies ranging from 10%-25% (143) . Although CCR2V64I has no effect on initial HIV transmission, studies show that seroconvertors bearing the CCR2V64I allele progress to AIDS significantly more slowly (2-4 years) than do CCR2 wild-type HIV-1 seroconvertors (142) . There is nonetheless substantial doubt that the CCR2V64I mechanism of action involves CCR2 directly, as this coreceptor is used by relatively few HIV-1 isolates in vitro and has not been consistently demonstrated to mediate HIV-1 infection in primary cells (144) . Although it is suggested that CCR2V64I is linked to another polymorphism that affects CCR5 expression or function, there is thus far no evidence to support this hypothesis. An association has been found between the CCR2V64I genotype and reduced CXCR4 levels on healthy donor PBMC (145) . A means by which this mutation prevents disease progression has recently been proposed, as the ability of CCR2V64I to form heterodimers with CCR5 and CXCR4, impairs the ability of both R5 and X4 HIV-1 strains to infect target cells (11) .
Raft Integrity Is Required for HIV-1 Infection
HIV-1 infection depends on multiple intermolecular interactions at the cell surface that occur sequentially. Accumulated evidence indicates that membrane rafts are fundamental in the lateral organization of the plasma membrane (123) . This organization is achieved because laterally diffusing lipid rafts can eventually coalesce with other rafts at the cell surface but not with other lipids encompassing a different membrane conformation. Certain membrane proteins are specifically raft-associated, whereas others are selectively excluded from these microdomains. This bulk separation of membrane-associated proteins between raft and non-raft membrane phases determines that only proteins sharing a preference for the same lipid environment will copatch into tightly associated domains, following stimulation that induces aggregation of membrane markers. This is of the utmost relevance, since HIV-1 infection activates lateral cell surface associations whose mechanisms nonetheless remain elusive. Interestingly, both HIV-1 receptors, that is, CD4 and the chemokine receptors, partition preferentially in membrane rafts (124, 146) . Moreover, permissive molecules that favor HIV-1 infection, such as CD44 and CD28, are found in and mediate reorganization of lipid rafts in living cells (147) . Physicochemical studies of gp120 interaction with defined glycosphingolipids (GSL) (148, 149) and inhibition of HIV-1 in vitro infection after treatment of cells with anti-GSL antibodies (149) suggest that raft components may also be important in HIV-1 infection.
Evidence suggests that raft preference by both chemokine receptors and CD4 is essential for fusion of the HIV-1 envelope and the cell membrane, probably by enabling gp120-induced lateral association of CD4 and CXCR4 (150) . Functional raft disruption caused by the decrease in cellular GSL or cholesterol levels abolishes HIV-1 infection. Since GSL and cholesterol are both basic components of lipid rafts, the inhibitory effect of these lipids may be mediated by impeding lateral diffusion of the HIV-1 co-receptors CD4 and CXCR4 or CCR5, a multimolecular organization critical for viral entry. This suggests that cell envelope fusion requires integrity of rafts bearing CD4 and CXCR4 or CCR5 receptors to enable viral infection in the target cell. This and the recently described budding of HIV-1 in rafts (151) point to chemokine receptors in membrane rafts as a possible target for new strategies to prevent and/or block HIV-1 infection. Such a therapeutic approach would be suitable for both X4 and R5 viral strains, and it would obviate the problem of resistance mutants generated using current treatments. The observation that chemokines trigger higher molecular organization of chemokine receptors, affecting their presence in rafts, may be an important step in this direction.
CONCLUDING REMARKS
Chemokines are the principal chemotactic factors implicated in the regulation of leukocyte traffic as well as in establishing lymphoid organ architecture. They regulate lymphocyte precursor entry into primary lymphoid organs as well as mature lymphocyte migration to secondary lymphoid organs, where following activation, they are responsible for triggering functional immune responses. The chemokines implicated in these activities constitute the homeostatic chemokines. Another large subset of chemokines appears to provoke inflammatory cell migration into tissues: the so-called inflammatory chemokines. Both chemokine subsets mediate their function by interacting with specific receptors belonging to the family of seventransmembrane, G protein-coupled receptors, expressed on the leukocyte surface.
Much information is available on the biochemical pathways activated by this large receptor family, but recent studies of signaling by chemokine and other ligands show that they also activate a tyrosine kinase pathway that shares many components with the biochemical pathway activated by the cytokine receptors: recruitment of the JAK and STAT transcriptional factors that trigger gene expression following nuclear translocation. As in the cytokine responses, activation of this pathway appears to depend on ligand-mediated receptor homodimerization. These findings open up a new pathway not only for intervention in chemokine responses, especially in those cases aimed at preventing tissue infiltration, but also for exploring the now obvious connection between chemokine and cytokine responses.
One of the most prominent biological functions of chemokines is to trigger chemotaxis. Chemokines elicit a chemotactic response through the activation of trimeric G i proteins and the subsequent Gβγ dimer release from the trimeric Gα i βγ complex. It is suggested that Gβγ dimers may function as a cell guidance system in eukaryotic cells. A cell moving along a chemotactic gradient acquires and maintains spatial as well as functional asymmetry between two opposite sides of the cell, the front and the rear. Chemokines may control the acquisition of front-rear polarity by triggering molecular rearrangements that lead to cellular asymmetry, such as relocalization of chemoattractant receptors to the leading cell edge and redistribution of adhesion receptors. The asymmetric distribution of chemokine receptors may thus be pivotal to the specific localization of the Gβγ guidance system at the cell leading edge.
An intriguing question is how cells engage these chemotactic signals at the cell front. It has been proposed that membrane proteins are selectively delivered to specialized cell surfaces in polarized neurons and epithelial cells by the clustering of specific proteins with glycosphingolipid and cholesterol-enriched membrane platforms, the raft microdomains. In nonpolarized cells, these rafts are homogeneously distributed over the cell surface; following chemoattractant stimulation, the membrane rafts and the specific membrane proteins associated to them redistribute preferentially to the leading edge. Membrane proteins excluded from rafts remain homogeneously distributed. Raft association appears to be a general requirement for G protein-coupled chemoattractant receptor migration to the leading edge; indeed, both heterotrimeric G proteins and chemokine receptors associate with membrane raft microdomains. Chemokine receptor polarization parallels the preferential redistribution to the leading edge of other raft-linked molecules, including those with no functional relevance in the polarization process. Disruption of chemokine receptor association with lipid rafts impedes cell polarization and inhibits chemotaxis. The lateral organization imposed by membrane raft microdomains is therefore fundamental to the engagement of all chemotactic signals at the proper cell location.
Finally, the identification of chemokine receptors as the HIV-1 receptors has opened up new horizons for understanding HIV-1 infection and for the development of rational approaches to its prevention. Chemokines block infection through a mechanism apparently independent of chemokine receptor signaling and downregulation, in which receptor di/oligomerization appears to cause the detachment of CD4. This process may be mediated by differential co-receptor expression on rafts, since raft disorganization also prevents HIV-1 infection. This mechanism of chemokine signaling via receptor di/oligomerization is implicated at the initial stages of many critical physiological and pathological processes. This perspective of chemokine immunobiology will provide a clearer comprehension of these conditions, possibly leading to new orientations toward the treatment of many inflammatory and infectious diseases. 
